137 related articles for article (PubMed ID: 25048360)
1. On the correlation between the structure of lyotropic carriers and the delivery profiles of two common NSAIDs.
Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2014 Oct; 122():231-240. PubMed ID: 25048360
[TBL] [Abstract][Full Text] [Related]
2. HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases.
Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
J Phys Chem B; 2014 Jun; 118(23):6277-87. PubMed ID: 24798650
[TBL] [Abstract][Full Text] [Related]
3. The effect of dendrimer generations on the structure of Q(G) LLC mesophase and drug release.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2014 Oct; 122():30-37. PubMed ID: 25016542
[TBL] [Abstract][Full Text] [Related]
4. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
[TBL] [Abstract][Full Text] [Related]
5. Structural effects of insulin-loading into HII mesophases monitored by electron paramagnetic resonance (EPR), small angle X-ray spectroscopy (SAXS), and attenuated total reflection Fourier transform spectroscopy (ATR-FTIR).
Mishraki T; Ottaviani MF; Shames AI; Aserin A; Garti N
J Phys Chem B; 2011 Jun; 115(25):8054-62. PubMed ID: 21591776
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
[TBL] [Abstract][Full Text] [Related]
7. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac.
Cohen-Avrahami M; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):131-8. PubMed ID: 20189781
[TBL] [Abstract][Full Text] [Related]
8. Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Sep; 115(34):10189-97. PubMed ID: 21749044
[TBL] [Abstract][Full Text] [Related]
9. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems.
Yariv D; Efrat R; Libster D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jul; 78(2):185-92. PubMed ID: 20363601
[TBL] [Abstract][Full Text] [Related]
10. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
[TBL] [Abstract][Full Text] [Related]
11. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac.
Efrat R; Aserin A; Garti N
J Colloid Interface Sci; 2008 May; 321(1):166-76. PubMed ID: 18279886
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium diclofenac loads on mesophase components and structure.
Efrat R; Shalev DE; Hoffman RE; Aserin A; Garti N
Langmuir; 2008 Jul; 24(14):7590-5. PubMed ID: 18547072
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C.
Bitan-Cherbakovsky L; Yuli-Amar I; Aserin A; Garti N
Langmuir; 2010 Mar; 26(5):3648-53. PubMed ID: 20175578
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of gabapentin into HII mesophases.
Achrai B; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Feb; 115(5):825-35. PubMed ID: 21182317
[TBL] [Abstract][Full Text] [Related]
15. Transitions induced by solubilized fat into reverse hexagonal mesophases.
Amar-Yuli I; Garti N
Colloids Surf B Biointerfaces; 2005 Jun; 43(2):72-82. PubMed ID: 15921902
[TBL] [Abstract][Full Text] [Related]
16. Lyotropic Cubic Phases for Drug Delivery: Diffusion and Sustained Release from the Mesophase Evaluated by Electrochemical Methods.
Nazaruk E; Miszta P; Filipek S; Górecka E; Landau EM; Bilewicz R
Langmuir; 2015 Nov; 31(46):12753-61. PubMed ID: 26513537
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous micellar solubilization within lyotropic liquid crystals interfaces.
Goldmünz EY; Aserin A; Ottaviani MF; Shames AI; Garti N
J Colloid Interface Sci; 2024 May; 672():552-563. PubMed ID: 38852356
[TBL] [Abstract][Full Text] [Related]
18. Incorporating a Tetrapeptide into Lyotropic Direct Hexagonal Mesophase.
Selivanova NM; Gubaidullin AT; Galyametdinov YG
J Phys Chem B; 2020 Apr; 124(13):2715-2722. PubMed ID: 32207304
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
20. Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: A comparative study.
de Araujo GRS; Azevedo Lima OV; Barreto Neujahr JP; Matos SS; de Souza TA; Dos Santos AM; Chorilli M; de Souza Araujo AA; Duarte MC; da Cunha Gonsalves JKM; de Souza Nunes R; Dos Santos MRV; Vitorino Sarmento VH; Moreira Lira AA
Int J Pharm; 2023 Apr; 636():122853. PubMed ID: 36931537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
